Effect of IL-6 on Alveolar Fibroblast Proliferation in Interstitial Lung Diseases

By Shahar I.   Fireman E.   Topilsky M.   Grief J.   Kivity S.   Spirer Z.   Efraim S.B.  

Clinical Immunology, Vol. 79, Iss. 3, 1996-06 ,pp. : 244-251

Academic Press

Access to resources Recommend Favorite

Weekly administration of paclitaxel and carboplatin with concurrent thoracic radiation in previously untreated elderly patients with locally advanced nonsmallcell lung cancer: A case series of 20 patients

By                                  

Molecular and Clinical Oncology, Vol. 2, Iss. 3, 2014-01 ,pp. : 454-460

Spandidos Publications

Access to resources Recommend Favorite

From Stem Cell Biology to The Treatment of Lung Diseases

By  

Current Stem Cell Research & Therapy, Vol. 12, Iss. 6, 2017-07 ,pp. : 493-505

Bentham Science Publishers

Access to resources Recommend Favorite

Retrospective analysis of capecitabine and oxaliplatin (XELOX) plus bevacizumab as a firstline treatment for Japanese patients with metastatic colorectal cancer

By                    

Molecular and Clinical Oncology, Vol. 2, Iss. 1, 2014-01 ,pp. : 134-138

Spandidos Publications

Access to resources Recommend Favorite

Acute cerebral arterial embolism following pemetrexed and carboplatin treatment in nonsmallcell lung cancer: A case report

By              

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 851-852

Spandidos Publications

Access to resources Recommend Favorite